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Abstract
1. The properdin levels in sera from mice bearing Ehrlich ascitic carcinoma and from rabbits
with Brown-Pearce carcinoma decrease inversely with the increase of the ascites or the tumors. In
the incipient period of tumor transplantation, the level rather rises. When the tumor is proliferating
or large, the level keeps falling or is low. On the contrary, when the tumor is regressing or dis-
appears, the level elevates or reverts to that before transplantation. Strong A and R III mice with
spontaneous mammary cancer have markedly low serum properdin levels as compared with those
of healthy mice. 2. The properdin levels are less than 2 units per milliliter of the serum in 44.4 per
cent of patients with gastric cancer, in 18.2 per cent of ones with non-malignant tumor and in 18.2
per cent of ones with gastric or duodenal ulcer. The abnormal low level has been found in 33.3 per
cent of patients without recurrence, who had undergone extended radical gastrectomy combined
with radical lymphadenectomy for gastric cancer. 3. Some correlation can be seen between the
serum properdin levels and the degree of progress of gastric cancer. 4. The cancer patients with
low total serum protein have lower serum properdin levels than those having nomal protein. 5. As
for influence of surgical operation on the serum properdin levels, there is observed a tendency that
a minor operation causes the levels to increase and a major operation causes the levels to fall. 6.
It has been inferred that the properdin system could be one of the host natural resistance against
cancer.
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Roughly speaking there are two cures for diseases. One is to eliminate the
cause of diseases positively from outside and the other is to increase the power
of resistance that individuals have.
In the majority of individuals various kinds of infection and other injuries
can be overcome with defense mechanisms with which they are naturally pro-
vided.
Recently the resistance of a human body is often neglected because of
notable development of chemotherapy in infectious diseases and in cancer, like-
wise, the body resistance has come to be like a neglected child with the remar-
kable development of surgery and with the advent of many anticancer agents.
However, it will take a long time before anticancer agents display the same
power against cancer as chemotherapy against infectious diseases. Now that
operations to stamp out cancer surgically have come to a limit and the existence
of specific immune antibody for cancer is doubtful, it is not without reason that
we need reappraisal of nonspecific immune antibody.
Among natural defense mechanisms, it is well known that there are whiteblood corpuscles, phagocytic action and so on, in cellular resistances.
Humoral defense mechanism was reported by LANOOIS1 in 1875, and the
existence of agglutinins and lysis for bacteria in serum became clear, and it is
now thought that these might have some relation to complement or to com-
ponents of complement2•3• In 1910 FREUND and KAMINER4 discovered that
serum of healthy persons contains a certain substance that can destroy human
cancer cells. In 1954 PILLEMER et al.r. discovered one new serum protein, pro-
perdin, while trying to separate the third component of complement. This is apowerful factor of natural resistance and offered a clue to explain natural defense
mechanisms. In 1957, SOUTHAM et al.6•7 reported that homotransplantation of
39
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human cancer cells is possible to cancer patients who have little serum properdin,
but it is not to healthy persons who possess considerable properdin, and there
is not appreciable difference between the former and the latter except in pro-
perdin levels.
It is now believed that this may be natural resistance to cancer, hut owing
to the difficulty in its assay, it has not been thoroughly investigated. Concerning
the relationship between transplantable tumor and serum propeadin levels in
tumor bearing animals there is only a brief report by HERBUT et al.f! In this
paper the auth~r describes about his attempts to investigate what influence the
growth of transplanted tumor has on serum properdin levels in tumor bearing
animals and next, chiefly in stomach cancer of human, whether there is any
difference between the serum properdin level in patients with malignant tumor
and that in non-malignant tumor, and whether there is any relation between
the development of the stomach cancer and properdin levels, and how the
properdin level is altered by the postoperative conditions of patients.
MATERIALS AND METHODS
The experimental animals used were 24 comparatively young adult rabbits,
weighing approximately 2 kg, and 60 mature female Cb strain mice, weighing
about 20 g. and Strong A and R III mice bearing the spontaneous mammary
cancer, 3 in each and 3 pair fed controls. The animals were placed on definite
diet for a week before the use. The experimental tumors transplanted were
Brown-Pearce carcinoma for rabbits and Ehrlich ascitic carcinoma for mice.
Brown-Pearce carnioma was transplanted into the rabbit posterior thigh
muscles, and the transplant was gouged aseptically 3 weeks after transplanta-
tion. The fresh tumor tissue so obtained was put in homogenizer excluding its
necrotic parts, minced gently, and made into suspension of 4 or 5 volumes with
physiological saline solution. Each 0.3 ml of this suspension was given to one
animal.
The rabbits were divided into 4 groups; Animals belonging to Group I
received bilateral injection of the suspension into posterior thigh muscles. In the
animals belonging to Group II the suspension' was injected into liver after open-
ing the abdominal cavity by the upper midline incision. In the animals of
Group III the suspension was injected into the portal vein after opening the
abdominal cavity as those in Group n. In those of Group IV the suspension was
injected into the posterior thigh muscle.
Before and after tumor transplantation the blood of each rabbit was taken
several times periodically. Selecting the time when they were hungry, approx-
imately 1 ml of the blood taken from the marginal vein of ear was allowed to
2
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clot at room temperature for 2 hours.
The serum was separated by centrifugation for 15 minutes at 4000 r. p. m.
and recentrifuged. These sera were stored at - 30 QC in the sealed tubes. After
finishing the blood collection of each series, properdin levels of all the samples
were measured simultaneously.
Rp and R3 prepared from guinea-pig sera were employed.
Ehrlichascitic carcinoma which developed in the abdominal cavity of mice
was taken through capillary tubes. 0.2 ml of 7 to 10 day old ascites containing
5 to 10 million cancer cells diluted with saline solution was transplanted into the
abdominal cavity of each mouse.
Before and after tumor transplantation, 0.5 ml of the blood was taken from
3 or 4 mice by means of cardiac puncture periodically.
The separated sera were pooled to yield a single serum specimen and pre-
served at -30°C till all the samples were ready.
Rp and R3 prepared from guinea-pig sera were used for properdin assay.
Sixty female Cb strain mice were divided into three groups of 20 mice
each. The ascitic carinomas from different mice were transplanted into the ab-
dominal cavity of each group at different time.
In the patients bearing tumor blood was taken from the elbow veins, early
in the morning before taking food in those in hospital, and before lunch in those
of out-patients. The serum properdin levels were measured the day after the
separation of serum, or separated serum was stored at -30°C in the sealed
vessels for further use. Rp prepared from sera of cancer patients and R3 made
of guinea-pig sera were used.
The foregoing manipulation was performed as aseptically as possible. The
method of properdin assay was described precisely in Part 1. The properdin
levels of all the samples in the same series were measured with the same re-
agents on the same day.
RESULTS
In 10 rabbits of Group I the transplanted tumor grew in about a week after
transplantation to the size of a little finger and in most of the cases it progres-
sively grew to the size of a pigeon egg in about 2 weeks, to a small hen-egg size
in about 3 weeks, and then the rabbits died in the state of cachexia. As shown
in Fig. 1, serum properdin levels tended to fall with the aggravation of tumor,
but a significant relation could not be seen between the number of days from
transplantation to death and the rate of fall of properdin levels. In one case of
natural healing in this group (Fig. 1, 6.), the tumor was palpable a week
after transplantation, but gradually regressed later. The affected locus was ope-
3
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Fig. 1. Change of properdin levels in rabbits with Brown·Pearce
carcinoma into posterior thigh muscles.
rated upon 40 days later, but tumor tissue could not be detected. In such a
case, properdin level, as if it had shared the fate of tumor, indicated only a
transitory fall in a week and gradually rose and then reverted to the level before
transplantation.
In 7 rabbits of Group II a decrease in weight and the lack of appetite were
found on the seventh day after transplantation.
Owing to the multiple growth of tum::>r all over the liver, they all died
within ab::>ut 2 weeks with the sudden increase of cachexia and hem::>rrhagic
ascites. Serum properdin indicated rather high levels 3 days after transplanta-
tion, but began to fall in a w~ek and fell rapidly 3 or 4 days before their death
(Fig. 2). One case in this group (Fig. 2, x) indicated a little decrease of appetite 8
clays after transplantation, but soon recovered and seemed to have been healed
naturally without any signs of the decrease in weight and cachexia, but after
14 days it began to languish rapidly and after 18 days died of tumor. The liver
swelled more than three times the original to 270g (normally the average weight
of 10 rabbits is 51 g). There could be seen hardly any parenchyma in the liver
which was occupied by the numerous whitish tumors, the size of a rice grain
and the accumulation of hemorrhagic ascites could be seen. Serum properdin
levels changed parallel with growth of the tumor, and rose transitorily about 2
weeks after transplantation and then fell suddenly, on the day before death the
level was one fifth that before transplantation.
4
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Fig. 2. Change of properdin levels in rabbits with Brown·Pearce
carcinoma transplanted into liver.
70 0;:;--:-1-~3~---:7=-------1:-I.4~- days
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In 3 rabbits of Group Ill, properdin levels reverted to the value before
operation one week after laparotomy and tended to rise a little in 2 weeks(Fig. 3).
In 4 rabbits of Group IV
two cases of rabbits whose
tumor grew very big and oc-
cupied the whole of their poste-
rior thigh muscle were laparo-
tomized 2 weeks and 3 weeks
after transplantation. The ve-
nous blood which returned from
the thigh with tumor and the
healthy one was taken separate-
ly from each v. ilica externa,
the arterial hlood was takell
from a. itica communis, and then properdin level of each blood was measured.
There was no significant difference between each serum properdin level(Table 1).
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Table 1.
Properdin titer of Properdin titer of venous Properdin titer of
No. of rabbit arterial blood blood from side with venous blood from
(units/ml.) tumor healthy side
11 after 2 weeks 6.6 I 6.5 6.1
14 after 3 weeks 5.1 I 4.6 5.4
J
Fig. 4. Change of properdin levels in mice
with Ehrlich ascites carcinoma.
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In the mice transplanted with Ehrlich ascitcs carcinoma all the animals showed
the swelling of the abdomen in 4 or 5 days after transplantation and their weights
increased remarkably, and all the mice died of tumor. Fifty per cent of them
were alive for two weeks or so,
and almost all animals died within
7 to 20 days. Serum properdin,
as could be seen in Fig. 4, fell
in inverse proportion to the ag-
gravation of tumor and the in-
crease in weight. For one or two
days after transplantation it indi-
cated rather higher level than
before transplantation, but in 3 to
6 days suddenly it fell to approxi-
mately one half the level before
transplantation and then it gra-
dually decreased and could not be
detected before death of mice.
In Strong A and R III strain
mice with spontaneous mammary
10 12 14 16 cancer the serum properdin levels
days after transplant. of tumor bearing mice fell one
fifth to one tenth of the levels of
healthy mice(Table 2).
Table 2.
I
Properdin titer in mice with
I
Properdin titer in healthy micemammary cancer
(units/ml. )
Strong A mice 1.0 9.4
R][ mice 2.2 8.9
6
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The serum properdin levels of patients with malignant tumor were found
to be less than 2 unts per milliliter of serum in 20 cases of 45 patients
(Table 3).
Among them, the level was less than 2 units in 13 cases of 25 with stomach
cancer, in 2 cases of 6 with colon cancer, in 2 cases of 5 with mammary cancer,
in one of 3 with cerebral tumor.
The stomach cancer may be classified according to its progress of liver
metastasis, lymphatic metastasis, peritoneal dissemination, infiltration in stomach
serosa and expressed respectively with H, L, P, S, and according to the extent
of them from what is mild to what is serious as Ho, HI, H2, H3, Lo-L4,
PO-P4 and So-S4. Types of cancer are expressed by the classification of
BoRRMANN14•
As shown in Tables 3 and 4, the properdin level tended to fall in advanced
cancer.
In 6 cases out of 33 patients having no malignant tumor the properdin level
was less than 2 units (Table 5). Among them, it was so in 2 of 11 suffering
from gastric or duodenal ulcer, and none of 5 cases of chronic mastitis and
mammary fibroadenoma showed abnomal level.
The effect of operative injury on properdin level was observed. The pro-
perdin levels were measured before and after operation, in the 7 cases where
gastrojejunostomy was performed by means of Billroth II method after the
operation of gastrectomy combined with radical lymphadenectomy for gastric
cancer, in 3 cases of gastric ulcer and in one case of gastric polyp where gas-
troduodenostomy was performed by Billroth I method and in cases of other
diseases.
In the case of gastric cancer where the extensive radical operation was per-
formed, in 2 to 3 weeks after operation the level seldom reverted to that
before operation, but in the case of gastric ulcer, gastric polyp where gas-
trectomy alone was performed, the level rather tended to rise after operation
as in Fig. 5. In mammary cancer in which radical mastectomy was performed,
in about 2 weeks after operation the level reverted to that prior to operation.
In appendicitis and inguinal hernia in which operative injury was slight, the
level hardly changed and in 2 cases of cerebral tumor where craniotomy with
extirpation of tumor had been performed, the level rose considerably after ope-
ration (Fig. 6).
The changes were observed in serum properdin levels after extensive radical
operation for gastric cancer, which means total removal of visible lymphnodes.
Properdin and complement are measured about a month after the radical
operation just before their discharge from hospital in 4 cases, and 4 months,
one year, 2 years, and 3 years after the radical operation in 15 cases. Among
7
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Malignant tumor dieseaseNo. I Age I Sex I
--~- r::- -- c
l
_-~::-----':I-~;';-·:-:-:r-:;;-e-l~-C--:-~-;-.----;-~""'~;--.t-::c-;--;-C-;O:""".~~~---:cS;:;-e:--;-)----;
I
3 58 i 0 I Gastric cancer with liver metast~sis
4 , 65 I 0 I' Recurrence of gastric cancer
5 I 52 I 0 Gastric cancer (n HsPoL:!S2)
6 56 0 Gastric cancer (IV HoPaLaSs)
7 48 0 Gastric cancer (IV HoPoL2S1)
8 35 !f Gastric cancer (IV HoP4LaS4)
9 64 0 Gastric cancer (IV HOPOLaS4)
10 62 0 Gastric cancer (]I HOPS4S4)
11 61 0 Gastric cancer (]I HoP3L4SI>
12 60 0 Gastric cancer (l[ HoPoL2SS)
13 73 0 Gastric cancer (I HoPoL2S1)
14 42 0 Gastric cancer (l[ HOP4LaS4)
15 67 0 Gastric cancer (]I HoPoLaSl)
16 67 0 Gastric cancer (]I HoPoL2So)
17 55 0 Gastric cancer (l[ HoPoL2S2)
18 54 !f Gastric cancer (l[ HoPoLISs)
19 49 !f Ga<;tric cancer (IV HoPoL2S2)
20 63 0 Gastric cancer (n HoPoL1S2)
21 71 (, Gastric cancer (]I HoPoLaSs)
22 63 0 Gastric cancer (JJI HoPoL2S2)
23 55 0 Gastric cancer (I HoPoL1So)
24 50 0 Gastric cancer (]I HOPOLaS4)
25 40 0 Gastric cancer (lIT HoPoT~)SJl
26 74 0 Rectum cancer
27 56 !f Rectum cancer
28 68 !f Rectum cancer
29 63 0 Rectum cancer
30 74 0 Colon cancer
31 54 0 Rectum cancer
32 72 !f Mammary cancer
33 40 !f Mammary cancer
34 47 !f Mammary cancer
35 41 !f Mammary cancer
36 46 !f Mammary cancer
37 42 !f Meningioma
38 33 !f Acoustic tumor
39 32 0 Hypophysial duct tumor
40 62 0 Cancer of mouth floor
41 26 0 Seminom with metastasis
42 32 !f Lymphosarcoma
43 I 42 0 Sarcoma
44 50 0 Liver cancer with lung metastasis
45 53 0 Lung cancer
$2
•
Table 3.
Properdin (units/m1.)
I 2--4 4-6 I
•
8
Acta Medica Okayama, Vol. 15 [1961], Iss. 1, Art. 4
http://escholarship.lib.okayama-u.ac.jp/amo/vol15/iss1/4
Serum Properdin and Cancer 47
Red cells IWhite rei" ITotal t"""m IL;"", fu",6oo CB. S. P. ) I Sedimentation rate ofproem red cells
432 x 104 5500 5.8g/dl 15-5% (30'-45') I 45-95 (1-2 h.)
342x10 4400 6.2 10-7.5 15-39
358x10 3800 7.1 20-15 16--43
312X10 7000 5-18
168xlO 4600 5.5 17.5-12.5 70-115
450x10 6100 5.8 7.5-2.5 10-25
515xlO 7000 6.7 15-28
366x10 6400 6.7 2.5-0 18-30
295x10 5800 6.0 5-2.5 25-46
368x10 7200 5.9 7.5-5.0 42-77
435x10 9400 I 7.0 27.5-20 41-82
332x10 7600 6.2 5-2.5 60-95
350x10 7200 5.5 15-10 15-35
428x10 5400 5.0 5-20
268x10 6400 6.0 12.5-10 20-42
269x10 6500 6.1 2.5-0 58-83
420xlO 7800 7.0 5-2.5 7-18
352x10 5800 5.6 2.5-0 9-25
4800 6.3 7.5-2.5
7400 5.3 5-2.5
4000 5.5 12.5-7.5
360x10 6600 6.7 5-0 3-7
5200 6.8 10-7.5 5-12
191x10 3200 5.4 15-5 100-108
346x10 6200 7.0 5-2.5 10-15
325x10 5900
405 x 10 5400 6.4 10-34
351 x10 4200 5.5 17.5-15 27-66
395x10 4900 5.2 10-20
42Ox10 5400 5.8 10-5
470 x 10 6500 7.5 15-12.5 40-70
396x10 5600 6.0 5-24
498x10 4300 7.0 10-5 28-60
359x10 7800 5.6 2.5-0 4-17
430x10 5000 6.8 9-25
440 X10 5300 6.4 7.5-2.5 10-28
330X10 6800 7.0 10-20
320x10 1200 6.0 15-10 35-45
468x10 10200
412x10 8200 6.7 22.5-20 14-30
9
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Table 4. a. Serum properdin levels and extent of metastasis. to the lymphnodes.
Properdin (unit/m!')
Metastasis to lymphnodes
~2 I 2<
Lo
Lt 1 2
L2 2 5
-
Ls 8 2
L4 1 1
b. Serum properdin levels and extent of infiltration to stomach serosa.
Properdin (unit/ml.)
Infiltration to stomach serosa
I~2 2<
So 2
SI 2 3 I
52 3 2
S3 3 2
S4 4 1
c. Serum properdin levels and extent of dissemination to peritoneum.
Dissemination to peritoneum
I
Properdin (unit/m!.)
~2 1 2<
Po 7 9
PI
P2
Pa 3 1
P4 2
10
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Pr:~
180 .
49
.-. : Gastric cancer
0 .. ·0 : Gastric ulcer or polyp
.,
14 21 2& days after op.
,on
180
160
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Fig. 5. Change of properdin levels in
postoperative patients.
: Appendicitis, 3 cases
: Inguinal hernia, 1 cases
x-x: Cerebral tumor, 2 cases
L-t::.. : Mammary cancer. 2 cases
14 21 days after op.
Fig'. 6. Change of properdin levels in
postoperative patients.
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Table 5.
I
I
Properdin (units/ml.)
No. Age Sex Non malignant tumor disease
I I I$2 2-4 4-6 6~
!
1 42 (; Duodenal ulcer
I
i
·
I
2 49 (; Gastric ulcer
I ·3 48 '1'
I
11
·
u
I4 63 ~
I
It I
·5 21 6 11 i
·I
I
I
6 25 (; (-;astroduodenal ulcer
·
:
! II
I
i
7 37 '1' Gastric ulcer
I ·
u
I
8 25 '1' I It
·
u
I9 57 0 It
·I 10 23 (; 11
·11 47 (; 11 c
12 48 ~ Gastroptosis
·13 45 ~ 11
·14 11 I (; Acute appendicitis
·I15 21 (; 11
·16 34 (; 11
·17 27 ~ Gastroptosis
·18 23 i' Chronic mastitis I
·
I
19 I 39 i' 11
·
I
I20
i
28 i' 11
·
i
21
i
29 if 11
·i 22 43 if Mammary fibroadenoma
·23 j 44 if Gastropolyp
·
i
I I24 62 (; Rectumpolyp I
·
I
25
I
66 (; Hernia sacrotalis dextra
·26 I 3 if Hernia ext. ing. sinistra
I ·
I
27 I Lumbar prolapsed disc
I
29 (; I
·28 41 (; 1/
·29 I 27 (; Cerebrale arachnoiditis
·30 ! 43 (; 11
·31 I 39 if 11
·32 I 40 (; Thromboangitis obliterans
I·33
i
48
I
(; Haemorrhoid
·I !
them were two patients, who had received the radical operation under the
diagnosis of gastric cancer and proved to be gastric ulcer from the histological
examination after the operation.
In 7 cases out of 19, the properdin level was less than 2 units, and with
the exception of the cases of recurrence and of ulcer, the level was the same in
12
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7--22 (1-2 h. )
4--5
2--5
Red c-ells
348x1(}1
380x10
360 )~10
257x10
381 X10
IWhite celb ITo~~um I Li"r funetiou (B. S. P. ) I Sed::f';;J't~i'brdl:-j
- ------ ... - .1 . .. ..1. _.._.. _ ..J .._. __...__. . L .__
4800 7.2g/c1J \ 10--5% (30'-45') I
7200 7.6 12.5--7.5
6900 7.1 5 -·-2. 5
5000 7.0 7.5--2.5
6200
501X10 8200 7.0 5-2.5 6--13
376x10 7000 6.8 10-18
360x10 4600 7.0 8.5--2.5 20-50.5
514XI0 7200 7.0 2.5-0 1-2
425x10 5400 6.0 10-7.5 3-9
307x10 4800 7.0 5-0 10--22
320x10 5400 7.5 15--12.5 16-23
394 >(}O 6200 7.0 5--2.5 5-15
408x10 8400 6.5 10--5 5--12
380x10 6400 6.0 5-0 7-20
482x10 12000 6.6 5--2.5
425x10 8800
421 x10 5600 15-10 3-7
514x10 7200 7.0 2.5-0 1--2
497x10 7600
5 cases out of 15. No significant relations could be seen between the titer of
serum complement and components of serum complement and properdin level.
The properdin levels showed a tendency to become abnormally lower in patients
over 2 years after operation (Table 6).
The relationship between serum properdin level and total serum proteins
13
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Table 6.
I
Nu. Age Time after
Properdin (unit/ml.)
Sex Type, Gastric cancer
operation
~2 1 2- 4 1 4- 6 1 6:£
1 63 0 n (HoPoLIS2) 20 days
·2 60 0 ][ (HoPoL2Sa) 20 11
·3 62 0 n (HoPaL4S4) 30 II
·4 73 0 I (HOPOL2SI) 30 11 •
5 59 0 n (HoPoL2S2) 4 months
·6 55 0 n (HoPoL2SI) 4 11
·7 64 0 IV (HoPoLaS4) 7 11
·8 49 0 ][ (HoPoL2So) 8 11 •
9 45 Sf IV (HoPoLlSo) 9 11
·10 54 0 ][ (HoPoL2Sl) 1 year •
11 48 0 IV (HoPoLaSo) 1 11 •
12 62 0 ][ (HoPoLlSo) 1y. 8m.
·13 31 0 Gastric ulcer 2 year .
14 51 0 II 2y. 1 m.
·15 60 0 ][ (HOPoL2S2) 2y. 3 m.
·16 55 0 n (HoPoL2SI) 2y. 6 m.
·17 54 0 ][ 3y. 3 m.
·18 43 0 ][ 3y. 6 m.
·19 56 0 n 3y. 6 m.
·
Table 7. Serum properdin levels and serum total protein values.
Total protein gm/lOO ml
I
Properdin (unit/ml.)
;:£2 I 2<
4.0-5.0 1
5.1-6.0 12 5
-
6.1-7.0 6 11
7.1- 2
has been observed. As in Table 7, low properdin level could be seen in many
cancer patients with low total protein. No significant relation could be recognized
among the number of white blood corpuscles, that of red blood corpuscles and
liver function.
14
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Complement and components
Red reil IWhi", Total Liver Sedimenta-of complement serum function toin rate of
C' I C'I I C'2 I C'a I C'4 s I cells protein (B.S.P.) red cells
4x 128 X 8x 8x 128 X 297 X 104 7000 5.5 10-7.5%(30'-45')
432xl0 7400
8x 128 X 16x 8x 128 X 275xl0 7200 6.8 30-30 3-10
8x 256 x 16x 16x 128 x 415x10 8000 7.6 12.5-7.5 8-24
8x 128 x 8x 32x 256 x 342x10 4400 6.2 10-7.5 15-36
4x 128 x 8x 32x 256 X 370x10 5800 7.5 5-2.5
8x 128 x 8x 16x 128 x 6.5 5-2.5 11-21
8x 64x 8x 8x 128 X 335xl0 8006 8.1 10-5 9-25
16x 64x 16x 32x 256 x 275xl0 5800 6.2 30-20 19-36
8x 32x 8x 16x 64x 350xl0 5200 6.5 12.5-10 18-43
8x 256 X 16x 32x 470xl0 6800 6.9 7.5-2.5 14-17
8x 128 x 16x 32x 256 x 385xl0 12000 6.3 10-5 16-41
2x 16x 2x 8x 128 x 455xl0 6400 6.3 7.5-5 11-45
4x 64x 8x 32x 128 x 3OOxl0 7400 6.9 7.5-5 3-19
8x 128 x 8x 8x 128 x 335xl0 5400 8.0 7.5-5 6-18
8x 64x 8x 16x 128 x 365XI0 8400 6.8 7.5-5 4-10
4x 128 x 8x 8x 256 x 410xl0 5200 7.0 7.5-5 7-18
COMMENT
It has been clarified that there is some correlation between serum pro-
perdin and the spread of Brown-Pearce carcinoma in rabbits, Ehrlich ascitic
carcinoma in Cb strain mice and spontaneous mammary cancer in strong A and
R III strain mice. In the incipient stage of the spread of transplanted tumor,
properdin level rather rises as if to check the spread, and when the ballance
between properdin and tumor is broken and the growing power of tumor over-
comes properdin level, tumor continues to aggravate and properdin level seems
to fall inversely. When Brown-Pearce carcinoma is transplanted into the liver
of rabbit, the fall of properdin is very notable as compared with the one trdllS-
planted into the thigh muscle, which seems to represent the function of the liver
as the place producing properdin. In the fourth group of rabbits a significant
difference can not be perceived between the properdin level of the blood from
the thigh with tumor and that of healthy thigh, which shows that serum pro-
perdin might not be affected by tumor tissue itself, or be affected little, if any.
It is said that when Ehrlich ascitic carcinoma is transplanted into abdominal
cavity of mice, cancer cell division reaches its peak in 3 and 5 days after trans-
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plantation. As if the growing power of the cancer cells has overcome properdin
level and then cancer cells continue to divide, . properdin suddenly decreases in 3
to 6 days after transplantation, which is a quite attractive phenomenon.
Concerning the serum properdin level of cancer patient, HINZ10 reported that
serum properdin level was nomaI in patients with malignant tumor, but many
other investigators7.11.12.13 found that properdin levels fell abnormally in many
cases of these patients, but reports on the relation between the ·progress of cancer,
its metastasis and operative invasion and serum properdin levels are only few in
number. In our department we have performed gastrectomy combined with
radical lymphadenectomy for patients with stomach cancer and obtained satis-
factory results and for the last ten years we have been continuing the researches
on the metastasis of stomach cancer.
Among the patients with malignant tumor there were notably many cases
with abnormally low properdien level as compared with non-malignant tumor
patients and normal persons. With regard to operative injury and serum pro-
perdin level, there is a repores claiming that there is no significant relationbetween the former and the latter owing to a great deviation of the properdin
level, but in the present work it was found that a slight operative injury caused
properdin to rise and a severe injury caused properdin to fall.
It can be said that, though craniotomy with tumor-exstirpation is a great
injury, the fact that properdin level rises a great deal after the operation seems
to correspond to Hoff's repore fi• Hoff states that the center of nonspecific
defense mechanism exists in the interbrain and reports that properdin rises if
air is injected into the ventricle. ROTIINO et al.12 as well as myself reported
that properdin level was low in patients with low total serum protein.
The evidence that properdin may have a power to interrupt the progress of
cancer or to inhibit the carcinogenesis can be obtained by taking out a great
guantity of properdin and administering it to cancer bearing individuals, or those
that are doomed to be attacked by cancer.
But it is difficult to prepare pure properdin and human beings require agreat quantity of it. Properdin being a high molecular weight proteins.17 has
antigenic action1ll, and thus it would be difficult to administer it to an animal ofdifferent species.
I-IERBUT1i1 inferred that, in the heterotransplantation of transplantable
lllllllaU carcinoma of the colon (HR132) in Wister rats, the fact that the rate oflUlllur "takes" rose in the case of administering cortisone, total body irradiation
allJ in the case of injecting a great (!u:llltity of ~yrnosan, would he ()roh:lhly
because of fall in the properdin level.
Later HERBUT et al.'20 said that properdin did not affect the rate of tumor
"takes", and HUBEY et al.21 claim that antitissue antibody has no bearing on
16
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properdin in his study of a rabbit skin homografts.
SoUTHAM et al.' reported in their homotransplantation studies with cul-
tivated human cancer cells that many examples of success in transplantation can
be seen in advanced cancer patients with a considerable fall in properdin.
Thus contradictory reports appear perhaps because these workers do not
take into consideration such factors as species antibody, histocompatibility and
so on. In lymphosarcoma 6C3RED in C3R mice, HERBUT et al.R saw that,
when tumor was growing or was large, serum properdin level fell, and when
it was regressing or disappeared completely, the level was normal or rather
higher.
It is now well known that the serum properdin levels from tumor bearing
animals vary inversely with the growth of tumors and, in stomach cancer, there
are many patients with low serum properdin level, and that in mice bearing
spontaneous mammary cancer and human cancer properdin is much lower as
compared with that of healthy ones or patients with non-malignant tumor.
Concerning the cytolysis of cancer cells in vitro by a normal human
serum, FREUND and KAMINERS~ report that, in abnormal serum or those
which are destitute of properdin, cytolysis of cancer cells does not take place
-these views indicate that there exists humoral natural immune antibody in-
cluding properdin system for cancer as well as for bacteria, virus and protowa.
The reason why properdin level is low in cancer patients is probably due
to the fact that cancer cells themselves absorb properdin, or that cancer tissue
polysaccharides, which combine with properdin to interfere with zymosan assay,
are released in the blood stream, or that toxin· injures the sites producing pro-
perdin, or that metabolic system including pantothenic acid22 may be disturbed,
or that these four coordinating with one another lower the properdin level.
CONCLUSIONS
L The properdin levels in sera from mice bearing Ehrlich ascitic carci-
noma and from rabbits with Brown-Pearce carcinoma decrease inversely with the
increase of the ascites or the tumors. In the incipient period of tumor trans-
plantation, the level rather rises. When the tumor is proliferating or large, the
level keeps falling or is low. On the contrary, when the tumor is regressing or
disappears, the level elevates or reverts to that before transplantation. Strong
A and R In mice with spontaneQus mammary cancer have markedly low serum
properdin levels as compared with those of healthy mice.
2. The properdin levels are less than 2 units per milliliter of the serum in
44.4 per cent of patients with gastric cancer, in 18.2 per cent of ones with
non-malignant tumor and in 18.2 per cent of ones with gastric or duodenal
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ulcer. The abnormal low level has been found in 33.3 per cent of patients
without recurrence, who had undergone extended radical gastrectomy combined
with radical lymphadenectomy for gastric cancer.
3. Some correlation can be seen between the serum properdin levels and
the degree of progress of gastric cancer.
4. The cancer patients with low total serum protein have lower serum
properdin levels than those having nomal protein.
5. As for influence of surgical operation on the serum properdin levels,
there is observed a tendency that a minor operation causes the levels to increase
and a major operation causes the levels to fall.
6. It has been inferred that the properdin system could be one of the host
natural resistance against cancer.
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